Hope for Women with Polycystic Ovarian Syndrome (PCOS)
Stanford University Medical Center in Palo Alto is currently conducting a PCOS study with promising results. PCOS in women is characterized with high levels of testosterone and insulin, adversely effecting the woman’s ovulation. In the study, the women are treated with a combination of the fertility drug Clomid and an insulin sensitizer called metformin. Once the effectiveness of a combination these drugs is determined, PCOS might be treatable with these combined medications.